Status:
UNKNOWN
Training Endoscopists to Perform On-site Rapid Cytological Evaluation for EUS-FNA of Solid Pancreatic Lesions
Lead Sponsor:
Changhai Hospital
Conditions:
Pancreatic Cancer
Eligibility:
All Genders
18+ years
Brief Summary
In China, there is a serious shortage of pathologists who can perform on-site cytological diagnosis. As a result, there are few centers that can conduct ROSE in China, which limits the diagnostic accu...
Eligibility Criteria
Inclusion
- age ≥18 years
- diagnosis or suspected of solid pancreatic mass based on previous imaging examination;
- EUS-FNA is achievable.
- signed informed consent letter
Exclusion
- pregnant female
- pancreatic cystic lesions
- anticoagulant/antiplatelet therapy cannot be suspended
- unable or refuse to provide informed consent
- coagulopathy (platelet count \<50 ×103/uL, international normalized ration \>1.5）
- severe cardiopulmonary dysfunction that cannot tolerate intravenous anesthesia
- with history of mental disease
- other medical conditions that are not suitable for EUS-FNA
Key Trial Info
Start Date :
December 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
November 1 2020
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT04509687
Start Date
December 1 2019
End Date
November 1 2020
Last Update
August 12 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Changhai Hospital
Shanghai, Shanghai Municipality, China, 210000